Clinical Trials List
2025-02-03 - 2033-05-03
Phase II/III
Recruiting4
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- PO-MING CHOW 無
- 莊佩儒 無
- - - 無
- Yu-Chieh Tsai 無
- 呂育全 無
- JIAN-HUA HONG 無
- CHUNG-HSIN CHEN 無
- 闕士傑 無
- 沈盈君 無
- 張晉誠 無
- 曾啟新 無
- Yeong-Shiau Pu 無
- 王中傑 無
- 邱士庭 無
- JHE-CYUAN GUO 無
- JEI-YIE HUANG 無
- FU-JEN HSUEH 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 彭南靖 無
- William Huang 無
- Tzu-chun Wei 無
- Tzu-Hsiang Hsu 無
- 沈書慧 Division of Radiology
- 康鈺玫 無
- Tzu-Ping Lin Division of Urology
- 陳威任 無
- Yu-Ming Liu 無
- Yen-Hwa Chang 無
- Chih-Chieh Lin 無
- Ming-Hsuan Ku 無
- 沈書慧 無
- 林可瀚 無
- Jiun-I Lai 無
- Hsiao-Jen Chung 無
- Tzu-Hao Huang 無
- 蔡承翰 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kai-Jie Yu 無
- Yung-Chang Lin 無
- Kung-Chu Ho Division of Nuclear Medicine
- I-hung Shao 無
- Jing-Ren Tseng 無
- 沈鼎文 無
- Rita cheng 無
- Hong-Cheng Gan 無
- Feng-Yuan Liu Division of Nuclear Medicine
- PO-HUNG LIN 無
- 吳俊德 無
- 沈鼎文 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8-10 participants
-
Global
432 participants
